nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—acquired immunodeficiency syndrome—hepatitis B	0.284	1	CtDrD
Abacavir—Nucleoside Reverse Transcriptase Inhibitors—Telbivudine—hepatitis B	0.185	0.392	CiPCiCtD
Abacavir—Nucleoside Reverse Transcriptase Inhibitors—Lamivudine—hepatitis B	0.14	0.297	CiPCiCtD
Abacavir—Cladribine—Entecavir—hepatitis B	0.101	0.547	CrCrCtD
Abacavir—Cladribine—Telbivudine—hepatitis B	0.0833	0.453	CrCrCtD
Abacavir—Nucleoside Analog—Telbivudine—hepatitis B	0.0833	0.177	CiPCiCtD
Abacavir—Nucleoside Analog—Lamivudine—hepatitis B	0.0631	0.134	CiPCiCtD
Abacavir—Other sleep disturbances—Lamivudine—hepatitis B	0.00447	0.0834	CcSEcCtD
Abacavir—Hyperamylasaemia—Lamivudine—hepatitis B	0.00257	0.0479	CcSEcCtD
Abacavir—Hepatitis B—Entecavir—hepatitis B	0.00183	0.0341	CcSEcCtD
Abacavir—ADH6—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00151	0.382	CbGpPWpGaD
Abacavir—Hepatitis B—Telbivudine—hepatitis B	0.0015	0.028	CcSEcCtD
Abacavir—Lactic acidosis—Entecavir—hepatitis B	0.00137	0.0255	CcSEcCtD
Abacavir—Depressive disorder—Lamivudine—hepatitis B	0.00114	0.0213	CcSEcCtD
Abacavir—Lactic acidosis—Telbivudine—hepatitis B	0.00112	0.021	CcSEcCtD
Abacavir—Dysthymic disorder—Lamivudine—hepatitis B	0.000999	0.0187	CcSEcCtD
Abacavir—Insulin resistance—Lamivudine—hepatitis B	0.000999	0.0187	CcSEcCtD
Abacavir—Aplasia pure red cell—Lamivudine—hepatitis B	0.000942	0.0176	CcSEcCtD
Abacavir—Hepatitis B—Lamivudine—hepatitis B	0.000846	0.0158	CcSEcCtD
Abacavir—Lipodystrophy—Lamivudine—hepatitis B	0.000846	0.0158	CcSEcCtD
Abacavir—Fat redistribution—Lamivudine—hepatitis B	0.000806	0.0151	CcSEcCtD
Abacavir—Breath sounds abnormal—Lamivudine—hepatitis B	0.000806	0.0151	CcSEcCtD
Abacavir—ADH6—liver—hepatitis B	0.000783	0.351	CbGeAlD
Abacavir—Buffalo hump—Lamivudine—hepatitis B	0.00077	0.0144	CcSEcCtD
Abacavir—Lipodystrophy acquired—Lamivudine—hepatitis B	0.000738	0.0138	CcSEcCtD
Abacavir—Lipohypertrophy—Lamivudine—hepatitis B	0.000708	0.0132	CcSEcCtD
Abacavir—Basedow's disease—Lamivudine—hepatitis B	0.000708	0.0132	CcSEcCtD
Abacavir—Hyperlactacidaemia—Lamivudine—hepatitis B	0.000681	0.0127	CcSEcCtD
Abacavir—Hypertrophy of breast—Lamivudine—hepatitis B	0.000656	0.0123	CcSEcCtD
Abacavir—Lactic acidosis—Lamivudine—hepatitis B	0.000633	0.0118	CcSEcCtD
Abacavir—UGT1A1—blood plasma—hepatitis B	0.000625	0.28	CbGeAlD
Abacavir—Splenomegaly—Lamivudine—hepatitis B	0.000557	0.0104	CcSEcCtD
Abacavir—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.000522	0.00974	CcSEcCtD
Abacavir—Hepatic steatosis—Lamivudine—hepatitis B	0.000512	0.00956	CcSEcCtD
Abacavir—Hepatomegaly—Entecavir—hepatitis B	0.000472	0.00881	CcSEcCtD
Abacavir—Myopathy—Adefovir Dipivoxil—hepatitis B	0.000464	0.00867	CcSEcCtD
Abacavir—Autoimmune disorder—Lamivudine—hepatitis B	0.000463	0.00865	CcSEcCtD
Abacavir—Sensitisation—Lamivudine—hepatitis B	0.000433	0.00808	CcSEcCtD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000425	0.108	CbGpPWpGaD
Abacavir—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.000398	0.00744	CcSEcCtD
Abacavir—Myopathy—Telbivudine—hepatitis B	0.000391	0.0073	CcSEcCtD
Abacavir—Hepatomegaly—Telbivudine—hepatitis B	0.000387	0.00724	CcSEcCtD
Abacavir—Opportunistic infection—Lamivudine—hepatitis B	0.000384	0.00717	CcSEcCtD
Abacavir—ADH6—Biological oxidations—GGT2—hepatitis B	0.000373	0.0944	CbGpPWpGaD
Abacavir—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.000342	0.00639	CcSEcCtD
Abacavir—Raised liver function tests—Lamivudine—hepatitis B	0.000335	0.00625	CcSEcCtD
Abacavir—Rhabdomyolysis—Telbivudine—hepatitis B	0.00031	0.00579	CcSEcCtD
Abacavir—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.000294	0.00549	CcSEcCtD
Abacavir—Musculoskeletal pain—Telbivudine—hepatitis B	0.000278	0.00518	CcSEcCtD
Abacavir—Hepatic failure—Entecavir—hepatitis B	0.00027	0.00504	CcSEcCtD
Abacavir—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.000269	0.00503	CcSEcCtD
Abacavir—Influenza like illness—Telbivudine—hepatitis B	0.000266	0.00497	CcSEcCtD
Abacavir—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.000263	0.00491	CcSEcCtD
Abacavir—Respiratory tract infection—Lamivudine—hepatitis B	0.000246	0.00459	CcSEcCtD
Abacavir—Breast enlargement—Lamivudine—hepatitis B	0.000238	0.00445	CcSEcCtD
Abacavir—Blood triglycerides increased—Lamivudine—hepatitis B	0.000236	0.00441	CcSEcCtD
Abacavir—ADK—blood—hepatitis B	0.000232	0.104	CbGeAlD
Abacavir—UGT1A1—blood—hepatitis B	0.000229	0.103	CbGeAlD
Abacavir—Blood creatinine increased—Entecavir—hepatitis B	0.000227	0.00424	CcSEcCtD
Abacavir—ADH6—Biological oxidations—CYP2A6—hepatitis B	0.000226	0.0572	CbGpPWpGaD
Abacavir—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.000225	0.00419	CcSEcCtD
Abacavir—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.000222	0.00414	CcSEcCtD
Abacavir—Abdominal pain upper—Entecavir—hepatitis B	0.000221	0.00413	CcSEcCtD
Abacavir—Myopathy—Lamivudine—hepatitis B	0.00022	0.00412	CcSEcCtD
Abacavir—Hepatomegaly—Lamivudine—hepatitis B	0.000218	0.00408	CcSEcCtD
Abacavir—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.000218	0.00408	CcSEcCtD
Abacavir—Throat sore—Lamivudine—hepatitis B	0.000214	0.004	CcSEcCtD
Abacavir—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.000213	0.00397	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.000209	0.00389	CcSEcCtD
Abacavir—Pancreatitis—Entecavir—hepatitis B	0.000205	0.00384	CcSEcCtD
Abacavir—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.0002	0.00374	CcSEcCtD
Abacavir—Migraine—Telbivudine—hepatitis B	0.000196	0.00366	CcSEcCtD
Abacavir—Neutropenia—Entecavir—hepatitis B	0.000196	0.00366	CcSEcCtD
Abacavir—Hyperglycaemia—Entecavir—hepatitis B	0.000189	0.00353	CcSEcCtD
Abacavir—Blood disorder—Lamivudine—hepatitis B	0.000185	0.00346	CcSEcCtD
Abacavir—Renal failure—Entecavir—hepatitis B	0.000184	0.00343	CcSEcCtD
Abacavir—Abdominal pain upper—Telbivudine—hepatitis B	0.000182	0.0034	CcSEcCtD
Abacavir—ADK—liver—hepatitis B	0.000181	0.0814	CbGeAlD
Abacavir—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.000179	0.00335	CcSEcCtD
Abacavir—Renal failure—Adefovir Dipivoxil—hepatitis B	0.000179	0.00335	CcSEcCtD
Abacavir—UGT1A1—liver—hepatitis B	0.000179	0.0803	CbGeAlD
Abacavir—Hepatobiliary disease—Entecavir—hepatitis B	0.000177	0.0033	CcSEcCtD
Abacavir—ADH6—Biological oxidations—GGT1—hepatitis B	0.000176	0.0447	CbGpPWpGaD
Abacavir—Gastritis—Telbivudine—hepatitis B	0.000176	0.00329	CcSEcCtD
Abacavir—Muscular weakness—Telbivudine—hepatitis B	0.000176	0.00328	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.000176	0.00328	CcSEcCtD
Abacavir—Rhabdomyolysis—Lamivudine—hepatitis B	0.000175	0.00326	CcSEcCtD
Abacavir—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.000172	0.00322	CcSEcCtD
Abacavir—Oropharyngeal pain—Lamivudine—hepatitis B	0.00017	0.00317	CcSEcCtD
Abacavir—Hepatitis—Entecavir—hepatitis B	0.000168	0.00313	CcSEcCtD
Abacavir—Abdominal discomfort—Telbivudine—hepatitis B	0.000165	0.00308	CcSEcCtD
Abacavir—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.000164	0.00305	CcSEcCtD
Abacavir—Hypercholesterolaemia—Lamivudine—hepatitis B	0.000163	0.00305	CcSEcCtD
Abacavir—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.000162	0.00303	CcSEcCtD
Abacavir—Neutropenia—Telbivudine—hepatitis B	0.000161	0.003	CcSEcCtD
Abacavir—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.000161	0.003	CcSEcCtD
Abacavir—Inflammation—Lamivudine—hepatitis B	0.000159	0.00298	CcSEcCtD
Abacavir—Musculoskeletal pain—Lamivudine—hepatitis B	0.000156	0.00292	CcSEcCtD
Abacavir—Immune system disorder—Entecavir—hepatitis B	0.000151	0.00283	CcSEcCtD
Abacavir—Renal failure—Telbivudine—hepatitis B	0.000151	0.00282	CcSEcCtD
Abacavir—Neuropathy peripheral—Telbivudine—hepatitis B	0.00015	0.00281	CcSEcCtD
Abacavir—Wheezing—Lamivudine—hepatitis B	0.00015	0.0028	CcSEcCtD
Abacavir—Alopecia—Entecavir—hepatitis B	0.000148	0.00277	CcSEcCtD
Abacavir—Malnutrition—Entecavir—hepatitis B	0.000146	0.00273	CcSEcCtD
Abacavir—Neuropathy—Lamivudine—hepatitis B	0.000145	0.00271	CcSEcCtD
Abacavir—Aplastic anaemia—Lamivudine—hepatitis B	0.000145	0.00271	CcSEcCtD
Abacavir—Hepatobiliary disease—Telbivudine—hepatitis B	0.000145	0.00271	CcSEcCtD
Abacavir—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.000142	0.00266	CcSEcCtD
Abacavir—Mouth ulceration—Lamivudine—hepatitis B	0.00014	0.00261	CcSEcCtD
Abacavir—Hepatitis—Telbivudine—hepatitis B	0.000138	0.00257	CcSEcCtD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000137	0.0347	CbGpPWpGaD
Abacavir—Pharyngitis—Telbivudine—hepatitis B	0.000137	0.00255	CcSEcCtD
Abacavir—Connective tissue disorder—Telbivudine—hepatitis B	0.000135	0.00253	CcSEcCtD
Abacavir—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000132	0.00246	CcSEcCtD
Abacavir—Lymphadenopathy—Lamivudine—hepatitis B	0.000131	0.00246	CcSEcCtD
Abacavir—Leukopenia—Entecavir—hepatitis B	0.000131	0.00244	CcSEcCtD
Abacavir—Sleep disorder—Lamivudine—hepatitis B	0.00013	0.00242	CcSEcCtD
Abacavir—Gastroenteritis—Lamivudine—hepatitis B	0.000127	0.00236	CcSEcCtD
Abacavir—Cough—Adefovir Dipivoxil—hepatitis B	0.000124	0.00232	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.000123	0.0023	CcSEcCtD
Abacavir—Myalgia—Adefovir Dipivoxil—hepatitis B	0.000121	0.00226	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00012	0.00225	CcSEcCtD
Abacavir—Malnutrition—Telbivudine—hepatitis B	0.00012	0.00224	CcSEcCtD
Abacavir—Anaphylactic shock—Entecavir—hepatitis B	0.000119	0.00222	CcSEcCtD
Abacavir—Infection—Entecavir—hepatitis B	0.000118	0.00221	CcSEcCtD
Abacavir—Nervous system disorder—Entecavir—hepatitis B	0.000117	0.00218	CcSEcCtD
Abacavir—Skin disorder—Entecavir—hepatitis B	0.000116	0.00216	CcSEcCtD
Abacavir—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.000114	0.00213	CcSEcCtD
Abacavir—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.000114	0.00213	CcSEcCtD
Abacavir—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000113	0.00211	CcSEcCtD
Abacavir—Ill-defined disorder—Telbivudine—hepatitis B	0.000111	0.00208	CcSEcCtD
Abacavir—Anorexia—Adefovir Dipivoxil—hepatitis B	0.000111	0.00207	CcSEcCtD
Abacavir—Migraine—Lamivudine—hepatitis B	0.00011	0.00206	CcSEcCtD
Abacavir—Malaise—Telbivudine—hepatitis B	0.000108	0.00202	CcSEcCtD
Abacavir—Insomnia—Entecavir—hepatitis B	0.000108	0.00201	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000106	0.00198	CcSEcCtD
Abacavir—Cough—Telbivudine—hepatitis B	0.000105	0.00195	CcSEcCtD
Abacavir—Liver function test abnormal—Lamivudine—hepatitis B	0.000104	0.00193	CcSEcCtD
Abacavir—Gastrointestinal disorder—Entecavir—hepatitis B	0.000103	0.00192	CcSEcCtD
Abacavir—Fatigue—Entecavir—hepatitis B	0.000103	0.00192	CcSEcCtD
Abacavir—Abdominal pain upper—Lamivudine—hepatitis B	0.000102	0.00191	CcSEcCtD
Abacavir—Myalgia—Telbivudine—hepatitis B	0.000102	0.00191	CcSEcCtD
Abacavir—Arthralgia—Telbivudine—hepatitis B	0.000102	0.00191	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000101	0.00189	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.000101	0.00189	CcSEcCtD
Abacavir—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000101	0.00189	CcSEcCtD
Abacavir—Discomfort—Telbivudine—hepatitis B	0.000101	0.00188	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—GGT2—hepatitis B	0.000101	0.0255	CbGpPWpGaD
Abacavir—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.0001	0.00187	CcSEcCtD
Abacavir—Muscular weakness—Lamivudine—hepatitis B	9.9e-05	0.00185	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Lamivudine—hepatitis B	9.9e-05	0.00185	CcSEcCtD
Abacavir—Gastrointestinal pain—Entecavir—hepatitis B	9.74e-05	0.00182	CcSEcCtD
Abacavir—Nervous system disorder—Telbivudine—hepatitis B	9.6e-05	0.00179	CcSEcCtD
Abacavir—Thrombocytopenia—Telbivudine—hepatitis B	9.58e-05	0.00179	CcSEcCtD
Abacavir—Pancreatitis—Lamivudine—hepatitis B	9.51e-05	0.00178	CcSEcCtD
Abacavir—Skin disorder—Telbivudine—hepatitis B	9.5e-05	0.00177	CcSEcCtD
Abacavir—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	9.5e-05	0.00177	CcSEcCtD
Abacavir—Body temperature increased—Entecavir—hepatitis B	9.42e-05	0.00176	CcSEcCtD
Abacavir—Abdominal pain—Entecavir—hepatitis B	9.42e-05	0.00176	CcSEcCtD
Abacavir—Bronchitis—Lamivudine—hepatitis B	9.33e-05	0.00174	CcSEcCtD
Abacavir—Abdominal discomfort—Lamivudine—hepatitis B	9.3e-05	0.00174	CcSEcCtD
Abacavir—Abdominal pain—Adefovir Dipivoxil—hepatitis B	9.19e-05	0.00172	CcSEcCtD
Abacavir—Body temperature increased—Adefovir Dipivoxil—hepatitis B	9.19e-05	0.00172	CcSEcCtD
Abacavir—Neutropenia—Lamivudine—hepatitis B	9.07e-05	0.00169	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Telbivudine—hepatitis B	8.91e-05	0.00166	CcSEcCtD
Abacavir—Insomnia—Telbivudine—hepatitis B	8.85e-05	0.00165	CcSEcCtD
Abacavir—Paraesthesia—Telbivudine—hepatitis B	8.79e-05	0.00164	CcSEcCtD
Abacavir—Hyperglycaemia—Lamivudine—hepatitis B	8.75e-05	0.00163	CcSEcCtD
Abacavir—Depression—Lamivudine—hepatitis B	8.62e-05	0.00161	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Lamivudine—hepatitis B	8.57e-05	0.0016	CcSEcCtD
Abacavir—Asthenia—Entecavir—hepatitis B	8.55e-05	0.0016	CcSEcCtD
Abacavir—Renal failure—Lamivudine—hepatitis B	8.5e-05	0.00159	CcSEcCtD
Abacavir—Neuropathy peripheral—Lamivudine—hepatitis B	8.47e-05	0.00158	CcSEcCtD
Abacavir—Gastrointestinal disorder—Telbivudine—hepatitis B	8.45e-05	0.00158	CcSEcCtD
Abacavir—Fatigue—Telbivudine—hepatitis B	8.44e-05	0.00158	CcSEcCtD
Abacavir—Stomatitis—Lamivudine—hepatitis B	8.43e-05	0.00157	CcSEcCtD
Abacavir—Pain—Telbivudine—hepatitis B	8.37e-05	0.00156	CcSEcCtD
Abacavir—Asthenia—Adefovir Dipivoxil—hepatitis B	8.34e-05	0.00156	CcSEcCtD
Abacavir—Pruritus—Adefovir Dipivoxil—hepatitis B	8.22e-05	0.00154	CcSEcCtD
Abacavir—Hepatobiliary disease—Lamivudine—hepatitis B	8.18e-05	0.00153	CcSEcCtD
Abacavir—Diarrhoea—Entecavir—hepatitis B	8.15e-05	0.00152	CcSEcCtD
Abacavir—Feeling abnormal—Telbivudine—hepatitis B	8.06e-05	0.00151	CcSEcCtD
Abacavir—Gastrointestinal pain—Telbivudine—hepatitis B	8e-05	0.00149	CcSEcCtD
Abacavir—Diarrhoea—Adefovir Dipivoxil—hepatitis B	7.95e-05	0.00148	CcSEcCtD
Abacavir—Dizziness—Entecavir—hepatitis B	7.88e-05	0.00147	CcSEcCtD
Abacavir—Hepatitis—Lamivudine—hepatitis B	7.76e-05	0.00145	CcSEcCtD
Abacavir—Abdominal pain—Telbivudine—hepatitis B	7.73e-05	0.00144	CcSEcCtD
Abacavir—Body temperature increased—Telbivudine—hepatitis B	7.73e-05	0.00144	CcSEcCtD
Abacavir—Pharyngitis—Lamivudine—hepatitis B	7.7e-05	0.00144	CcSEcCtD
Abacavir—Connective tissue disorder—Lamivudine—hepatitis B	7.63e-05	0.00142	CcSEcCtD
Abacavir—Vomiting—Entecavir—hepatitis B	7.57e-05	0.00141	CcSEcCtD
Abacavir—Rash—Entecavir—hepatitis B	7.51e-05	0.0014	CcSEcCtD
Abacavir—Dermatitis—Entecavir—hepatitis B	7.5e-05	0.0014	CcSEcCtD
Abacavir—Headache—Entecavir—hepatitis B	7.46e-05	0.00139	CcSEcCtD
Abacavir—Vomiting—Adefovir Dipivoxil—hepatitis B	7.39e-05	0.00138	CcSEcCtD
Abacavir—Erythema multiforme—Lamivudine—hepatitis B	7.34e-05	0.00137	CcSEcCtD
Abacavir—Rash—Adefovir Dipivoxil—hepatitis B	7.33e-05	0.00137	CcSEcCtD
Abacavir—Dermatitis—Adefovir Dipivoxil—hepatitis B	7.32e-05	0.00137	CcSEcCtD
Abacavir—Headache—Adefovir Dipivoxil—hepatitis B	7.28e-05	0.00136	CcSEcCtD
Abacavir—Nausea—Entecavir—hepatitis B	7.07e-05	0.00132	CcSEcCtD
Abacavir—Asthenia—Telbivudine—hepatitis B	7.02e-05	0.00131	CcSEcCtD
Abacavir—Immune system disorder—Lamivudine—hepatitis B	7.01e-05	0.00131	CcSEcCtD
Abacavir—Chills—Lamivudine—hepatitis B	6.96e-05	0.0013	CcSEcCtD
Abacavir—Pruritus—Telbivudine—hepatitis B	6.92e-05	0.00129	CcSEcCtD
Abacavir—Nausea—Adefovir Dipivoxil—hepatitis B	6.9e-05	0.00129	CcSEcCtD
Abacavir—Alopecia—Lamivudine—hepatitis B	6.86e-05	0.00128	CcSEcCtD
Abacavir—Malnutrition—Lamivudine—hepatitis B	6.76e-05	0.00126	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—GGT2—hepatitis B	6.72e-05	0.017	CbGpPWpGaD
Abacavir—Diarrhoea—Telbivudine—hepatitis B	6.69e-05	0.00125	CcSEcCtD
Abacavir—ADH6—Metabolism—AKR1B1—hepatitis B	6.65e-05	0.0168	CbGpPWpGaD
Abacavir—Dizziness—Telbivudine—hepatitis B	6.47e-05	0.00121	CcSEcCtD
Abacavir—ADH6—Metabolism—GGT2—hepatitis B	6.38e-05	0.0161	CbGpPWpGaD
Abacavir—Ill-defined disorder—Lamivudine—hepatitis B	6.27e-05	0.00117	CcSEcCtD
Abacavir—Anaemia—Lamivudine—hepatitis B	6.24e-05	0.00117	CcSEcCtD
Abacavir—Vomiting—Telbivudine—hepatitis B	6.22e-05	0.00116	CcSEcCtD
Abacavir—Rash—Telbivudine—hepatitis B	6.17e-05	0.00115	CcSEcCtD
Abacavir—Dermatitis—Telbivudine—hepatitis B	6.16e-05	0.00115	CcSEcCtD
Abacavir—Headache—Telbivudine—hepatitis B	6.13e-05	0.00114	CcSEcCtD
Abacavir—Malaise—Lamivudine—hepatitis B	6.09e-05	0.00114	CcSEcCtD
Abacavir—Vertigo—Lamivudine—hepatitis B	6.07e-05	0.00113	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—AKR1B1—hepatitis B	6.06e-05	0.0153	CbGpPWpGaD
Abacavir—Leukopenia—Lamivudine—hepatitis B	6.05e-05	0.00113	CcSEcCtD
Abacavir—Cough—Lamivudine—hepatitis B	5.9e-05	0.0011	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—GGT2—hepatitis B	5.89e-05	0.0149	CbGpPWpGaD
Abacavir—Convulsion—Lamivudine—hepatitis B	5.85e-05	0.00109	CcSEcCtD
Abacavir—Nausea—Telbivudine—hepatitis B	5.81e-05	0.00109	CcSEcCtD
Abacavir—Myalgia—Lamivudine—hepatitis B	5.75e-05	0.00107	CcSEcCtD
Abacavir—Arthralgia—Lamivudine—hepatitis B	5.75e-05	0.00107	CcSEcCtD
Abacavir—Anxiety—Lamivudine—hepatitis B	5.73e-05	0.00107	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	5.71e-05	0.00107	CcSEcCtD
Abacavir—Discomfort—Lamivudine—hepatitis B	5.68e-05	0.00106	CcSEcCtD
Abacavir—Anaphylactic shock—Lamivudine—hepatitis B	5.51e-05	0.00103	CcSEcCtD
Abacavir—Oedema—Lamivudine—hepatitis B	5.51e-05	0.00103	CcSEcCtD
Abacavir—Infection—Lamivudine—hepatitis B	5.48e-05	0.00102	CcSEcCtD
Abacavir—Nervous system disorder—Lamivudine—hepatitis B	5.41e-05	0.00101	CcSEcCtD
Abacavir—Thrombocytopenia—Lamivudine—hepatitis B	5.4e-05	0.00101	CcSEcCtD
Abacavir—Skin disorder—Lamivudine—hepatitis B	5.36e-05	0.001	CcSEcCtD
Abacavir—Anorexia—Lamivudine—hepatitis B	5.26e-05	0.000982	CcSEcCtD
Abacavir—Hypotension—Lamivudine—hepatitis B	5.15e-05	0.000962	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Lamivudine—hepatitis B	5.02e-05	0.000938	CcSEcCtD
Abacavir—Insomnia—Lamivudine—hepatitis B	4.99e-05	0.000931	CcSEcCtD
Abacavir—Paraesthesia—Lamivudine—hepatitis B	4.95e-05	0.000925	CcSEcCtD
Abacavir—Dyspnoea—Lamivudine—hepatitis B	4.92e-05	0.000918	CcSEcCtD
Abacavir—Decreased appetite—Lamivudine—hepatitis B	4.79e-05	0.000895	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—GGT1—hepatitis B	4.76e-05	0.0121	CbGpPWpGaD
Abacavir—Gastrointestinal disorder—Lamivudine—hepatitis B	4.76e-05	0.000889	CcSEcCtD
Abacavir—Fatigue—Lamivudine—hepatitis B	4.75e-05	0.000888	CcSEcCtD
Abacavir—Pain—Lamivudine—hepatitis B	4.72e-05	0.000881	CcSEcCtD
Abacavir—Feeling abnormal—Lamivudine—hepatitis B	4.54e-05	0.000849	CcSEcCtD
Abacavir—Gastrointestinal pain—Lamivudine—hepatitis B	4.51e-05	0.000842	CcSEcCtD
Abacavir—Urticaria—Lamivudine—hepatitis B	4.38e-05	0.000818	CcSEcCtD
Abacavir—Body temperature increased—Lamivudine—hepatitis B	4.36e-05	0.000814	CcSEcCtD
Abacavir—Abdominal pain—Lamivudine—hepatitis B	4.36e-05	0.000814	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—CYP2A6—hepatitis B	4.07e-05	0.0103	CbGpPWpGaD
Abacavir—Hypersensitivity—Lamivudine—hepatitis B	4.06e-05	0.000759	CcSEcCtD
Abacavir—Asthenia—Lamivudine—hepatitis B	3.96e-05	0.000739	CcSEcCtD
Abacavir—Pruritus—Lamivudine—hepatitis B	3.9e-05	0.000729	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	3.89e-05	0.00984	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CYP2A6—hepatitis B	3.86e-05	0.00978	CbGpPWpGaD
Abacavir—Diarrhoea—Lamivudine—hepatitis B	3.77e-05	0.000705	CcSEcCtD
Abacavir—Dizziness—Lamivudine—hepatitis B	3.65e-05	0.000681	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—CYP2A6—hepatitis B	3.57e-05	0.00904	CbGpPWpGaD
Abacavir—ADK—Metabolism—AKR1B1—hepatitis B	3.55e-05	0.00899	CbGpPWpGaD
Abacavir—Vomiting—Lamivudine—hepatitis B	3.51e-05	0.000655	CcSEcCtD
Abacavir—ADH6—Metabolism—GOT2—hepatitis B	3.49e-05	0.00885	CbGpPWpGaD
Abacavir—Rash—Lamivudine—hepatitis B	3.48e-05	0.000649	CcSEcCtD
Abacavir—Dermatitis—Lamivudine—hepatitis B	3.47e-05	0.000649	CcSEcCtD
Abacavir—Headache—Lamivudine—hepatitis B	3.45e-05	0.000645	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	3.45e-05	0.00874	CbGpPWpGaD
Abacavir—ADK—Metabolism—GGT2—hepatitis B	3.41e-05	0.00862	CbGpPWpGaD
Abacavir—Nausea—Lamivudine—hepatitis B	3.28e-05	0.000612	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—GGT1—hepatitis B	3.18e-05	0.00804	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GOT1—hepatitis B	3.02e-05	0.00764	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GGT1—hepatitis B	3.02e-05	0.00764	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GGT1—hepatitis B	2.79e-05	0.00705	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	2.69e-05	0.00682	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	2.51e-05	0.00637	CbGpPWpGaD
Abacavir—ADK—Metabolism—CYP2A6—hepatitis B	2.06e-05	0.00522	CbGpPWpGaD
Abacavir—ADK—Metabolism—GOT2—hepatitis B	1.87e-05	0.00472	CbGpPWpGaD
Abacavir—ADK—Metabolism—GGT1—hepatitis B	1.61e-05	0.00408	CbGpPWpGaD
Abacavir—ADK—Metabolism—GOT1—hepatitis B	1.61e-05	0.00408	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALB—hepatitis B	1.6e-05	0.00406	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PTEN—hepatitis B	1.22e-05	0.0031	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—TGFB1—hepatitis B	1.07e-05	0.00271	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AKR1B1—hepatitis B	1.05e-05	0.00266	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GGT2—hepatitis B	1.01e-05	0.00255	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALB—hepatitis B	8.57e-06	0.00217	CbGpPWpGaD
Abacavir—ADK—Metabolism—PTEN—hepatitis B	6.54e-06	0.00165	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP2A6—hepatitis B	6.11e-06	0.00155	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GOT2—hepatitis B	5.52e-06	0.0014	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GOT1—hepatitis B	4.77e-06	0.00121	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GGT1—hepatitis B	4.77e-06	0.00121	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALB—hepatitis B	2.54e-06	0.000642	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PTEN—hepatitis B	1.93e-06	0.00049	CbGpPWpGaD
